Cargando…

Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus

Zika virus (ZIKV) is a significant public health concern due to the pathogen’s ability to be transmitted by either mosquito bite or sexual transmission, allowing spread to occur throughout the world. The potential consequences of ZIKV infection to human health, specifically neonates, necessitates th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffen, Tara, Hassert, Mariah, Hoft, Stella G., Stone, E. Taylor, Zhang, Jianfeng, Geerling, Elizabeth, Grimberg, Brian T., Roberts, M. Scot, Pinto, Amelia K., Brien, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349816/ https://www.ncbi.nlm.nih.gov/pubmed/32272595 http://dx.doi.org/10.3390/vaccines8020170

Ejemplares similares

The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model
por: Dickson, Alexandria, et al.
Publicado: (2023)

Obesity Enhances Disease Severity in Female Mice Following West Nile Virus Infection
por: Geerling, Elizabeth, et al.
Publicado: (2021)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection
por: Hassert, Mariah, et al.
Publicado: (2021)

Identification of Protective CD8 T Cell Responses in a Mouse Model of Zika Virus Infection
por: Hassert, Mariah, et al.
Publicado: (2019)

Diagnostic differentiation of Zika and dengue virus exposure by analyzing T cell receptor sequences from peripheral blood of infected HLA-A2 transgenic mice
por: Hassert, Mariah, et al.
Publicado: (2020)

mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
por: Hassert, Mariah, et al.
Publicado: (2020)

CD4(+)T cells mediate protection against Zika associated severe disease in a mouse model of infection
por: Hassert, Mariah, et al.
Publicado: (2018)

Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells
por: Hassert, Mariah, et al.
Publicado: (2019)

Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination
por: Stone, E. Taylor, et al.
Publicado: (2022)

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
por: To, Albert, et al.
Publicado: (2018)

Current Flavivirus Research Important for Vaccine Development
por: Geerling, Elizabeth, et al.
Publicado: (2020)

Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus
por: Pantoja, Petraleigh, et al.
Publicado: (2017)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Folegatti, Pedro M., et al.
Publicado: (2019)

Time elapsed between Zika and dengue virus infections affects antibody and T cell responses
por: Pérez-Guzmán, Erick X., et al.
Publicado: (2019)

Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies
por: Serrano-Collazo, Crisanta, et al.
Publicado: (2020)

Tissue resident memory T cells- A new benchmark for the induction of vaccine-induced mucosal immunity
por: Hassert, Mariah, et al.
Publicado: (2022)

SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells
por: Patra, Tapas, et al.
Publicado: (2020)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021)

Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles
por: Brzuska, Gabriela, et al.
Publicado: (2022)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Identification of immunodominant T cell epitopes induced by natural Zika virus infection
por: Eickhoff, Christopher S., et al.
Publicado: (2023)

Investigation of the immunogenicity of Zika glycan loop
por: Henderson, Elizabeth A., et al.
Publicado: (2020)

Immunogenicity of the recombinant adenovirus fusion-expressing E0-E2 gene of the classical swine fever virus
por: Zhang, Heng, et al.
Publicado: (2022)

Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
por: Tanelus, Manette, et al.
Publicado: (2023)

Complement activation by recombinant adenoviruses
por: Cichon, G, et al.
Publicado: (2002)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Metal coordinating inhibitors of Rift Valley fever virus replication
por: Geerling, Elizabeth, et al.
Publicado: (2022)

Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes
por: Fu, Yang, et al.
Publicado: (2022)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines
por: Lin, Shih-Chang, et al.
Publicado: (2011)

Canine Recombinant Adenovirus Vector Induces an Immunogenicity-Related Gene Expression Profile in Skin-Migrated CD11b(+) -Type DCs
por: Contreras, Vanessa, et al.
Publicado: (2012)

Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus
por: Zhang, Zhe, et al.
Publicado: (2022)

Sensitive and immunogen-specific serological detection of Rodentibacter pneumotropicus infections in mice
por: Fingas, Felix, et al.
Publicado: (2019)

Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2018)

Characterization of a Species E Adenovirus Vector as a Zika virus vaccine
por: Bullard, Brianna L., et al.
Publicado: (2020)

2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine
por: Tasker, Sybil, et al.
Publicado: (2018)

Dose Effects of Recombinant Adenovirus Immunization in Rodents
por: Weaver, Eric A.
Publicado: (2019)

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
por: Capone, Stefania, et al.
Publicado: (2021)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
por: Folegatti, Pedro M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kqgpgl6ttmsdns324ulup1sebs